1
2
3
STEP 1 OF 3Your symptoms
and product.
Select all symptoms you experienced and the specific Dupixent Lawsuit product involved.
Selected Case
Dupixent Lawsuit
Sanofi and Regeneron’s biologic drug Dupixent (dupilumab) has been linked in patient reports and emerging studies to serious eye conditions, inflammatory reactions, and other complications, raising concerns about inadequate warnings.
Estimated Range
$1.5M+
Status
Active 15 cases
*Claim outcomes depend on diagnosis, timing, and medical records. Similar cases may be valued differently based on each person’s circumstances.